Dr Mary Kerr, CEO of KaNDy Therapeutics presents at the Women’s Health and Technology Innovation Forum at King’s College London, Strand Campus, London

KaNDy Therapeutics announces the appointment of Andrew Kay as Independent Chairman of the Board

Dr Mary Kerr CEO KaNDy Therapeutics presents at the Biotech Showcase, San Francisco

KaNDy Therapeutics announces initiation of Phase 2b trial of NT-814 for the treatment of troublesome post-menopausal symptoms

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt